Differentiating poor prognosis from treatment-related fluctuations in Guillain-Barré syndrome for repeating immunoglobulin treatment: an illustrative case report
This case illustrates the clinical difficulty of deciding whether repeated immunotherapy is justified in severe GBS, and current evidence discourages routine second IVIG courses in patients with poor prognosis who fail to respond; this recommendation does not necessarily apply to TRF, where renewed immunotherapy may be...